A multicentre study on grey matter morphometric biomarkers for classifying early schizophrenia and parkinson’s disease psychosis
Abstract Psychotic symptoms occur in a majority of schizophrenia patients and in ~50% of all Parkinson’s disease (PD) patients. Altered grey matter (GM) structure within several brain areas and networks may contribute to their pathogenesis. Little is known, however, about transdiagnostic similaritie...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-06-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-023-00522-z |